Important note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
The New York Times - November 22, 2007
Paul Vitello
Through a spokesman, Eric Phillips, Ms. Rice declined to say whether criminal charges might be considered against the anesthesiologist, Dr. Harvey S. Finkelstein.
"Given the urgent need to identify exactly what happened and to fully understand the scope of the possible threat, the district attorney made the decision to launch an immediate investigation," Mr. Phillips said.
Neither Dr. Finkelstein nor his spokesman replied to messages yesterday requesting comment.
On Nov. 10, the State Health Department notified 628 of Dr. Finkelstein's patients that they might have been exposed to hepatitis C, hepatitis B, or H.I.V. from 2000 to 2005, as a result of Dr. Finkelstein's improper reuse of syringes in his clinic, which specializes in pain management. The department first confirmed the problem in January 2005 but took 34 months to notify patients.
The state health commissioner, Richard F. Daines, has recommended that anyone who received an injection from Dr. Finkelstein in his private practice, which began in the 1980s, should be tested for the two types of hepatitis and H.I.V. The recommendation came after hundreds of current and former patients contacted health authorities to ask if they should be tested. So far, hundreds of patients have had the blood tests; one had a positive result for hepatitis B, though health officials said further tests were needed to determine whether it was connected to Dr. Finkelstein's work.
In January 2005, State Health Department epidemiologists traced the transmission of a hepatitis C infection to his private clinic in Plainview. Dr. Finkelstein's case was reviewed by the Office of Professional Medical Conduct, but by the time the review took place, Dr. Finkelstein had changed his methods to comply with standard practice.
071122
NYT071113
Copyright © 2007 - The New York Times Company. All Rights Reserved. All New York Times articles contained on the AEGiS web site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of The New York Times Company. You may not alter or remove any trademark, copyright or other notice from copies of the content. However, you may download articles (one machine readable copy and one print copy per page) for your personal, noncommercial use only.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .